Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Non Operating Income (2020 - 2023)

Historic Non Operating Income for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to $2.3 million.

  • Therapeutics' Non Operating Income rose 5817.57% to $2.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.3 million, marking a year-over-year increase of 42447.62%. This contributed to the annual value of $10.3 million for FY2023, which is 42447.62% up from last year.
  • Therapeutics' Non Operating Income amounted to $2.3 million in Q4 2023, which was up 5817.57% from $2.5 million recorded in Q3 2023.
  • Therapeutics' Non Operating Income's 5-year high stood at $3.1 million during Q2 2023, with a 5-year trough of -$275000.0 in Q2 2022.
  • Moreover, its 4-year median value for Non Operating Income was $350000.0 (2020), whereas its average is $846125.0.
  • The largest annual percentage gain for Therapeutics' Non Operating Income in the last 5 years was 130952.38% (2022), contrasted with its biggest fall of 84827.59% (2022).
  • Therapeutics' Non Operating Income (Quarter) stood at $549000.0 in 2020, then tumbled by 80.87% to $105000.0 in 2021, then surged by 1309.52% to $1.5 million in 2022, then skyrocketed by 58.18% to $2.3 million in 2023.
  • Its Non Operating Income was $2.3 million in Q4 2023, compared to $2.5 million in Q3 2023 and $3.1 million in Q2 2023.